GLP-1 drugs and aspiration risk
US$ 26.69
semaglutide vs tirzepatide vs ozempic Zepbound for Weight Loss Semaglutide vs. Tirzepatide - Global
Description
Footnotes DISCLOSURE: The author declares no conflict of interest References 1.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al
AAMC News
Conclusions Semaglutide treatment led to a 52% reduction in UACR levels in non-diabetic and overweight patients diagnosed with CKD
Preclinical studies indicate that GLP-1 RAs can attenuate atherosclerosis by reducing vascular inflammation, lowering oxidative stress, and inhibiting the proliferation and activation of vascular smooth muscle cells [51, 52]
The below chart outlines some of the key similarities and differences between once-weekly tirzepatide and injectable semaglutide
